tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ALXO Stock Latest News

ALX Oncology CMO Sophia Randolph Announces Resignation
Company AnnouncementsALX Oncology CMO Sophia Randolph Announces Resignation
11d ago
8K
ALXO
ALX Oncology announces first patients dosed with evorpacept, sarclisa
PremiumThe Fly
ALX Oncology announces first patients dosed with evorpacept, sarclisa
1M ago
SNY
ALXO
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
LC
ALXO
ALX Oncology reports Q2 EPS (76c), consensus (77c)
PremiumThe Fly
ALX Oncology reports Q2 EPS (76c), consensus (77c)
2M ago
ALXO
ALX Oncology Enhances Board with Expert Appointment, Meets Nasdaq Standards
PremiumCompany Announcements
ALX Oncology Enhances Board with Expert Appointment, Meets Nasdaq Standards
2M ago
8K
ALXO
ALX Oncology price target lowered to $5 from $14 at Stifel
PremiumThe FlyALX Oncology price target lowered to $5 from $14 at Stifel
3M ago
ALXO
ALX Oncology announces topline data from ASPEN-06 clinical trial
Premium
The Fly
ALX Oncology announces topline data from ASPEN-06 clinical trial
3M ago
ALXO
ALX Oncology trading resumes
Premium
The Fly
ALX Oncology trading resumes
3M ago
ALXO
ALX Oncology trading halted, news pending
PremiumThe Fly
ALX Oncology trading halted, news pending
3M ago
ALXO
ALX Oncology presents data from Phase 1 ASPEN-07 clinical trial
PremiumThe Fly
ALX Oncology presents data from Phase 1 ASPEN-07 clinical trial
5M ago
ALXO
ALX Oncology price target raised to $25 from $20 at H.C. Wainwright
PremiumThe Fly
ALX Oncology price target raised to $25 from $20 at H.C. Wainwright
5M ago
ALXO
ALX Oncology reports Q1 EPS (71c), consensus (84c)
PremiumThe Fly
ALX Oncology reports Q1 EPS (71c), consensus (84c)
5M ago
ALXO
ALX Oncology appoints Dillon as Chief Business Officer
PremiumThe FlyALX Oncology appoints Dillon as Chief Business Officer
5M ago
ALXO
ALX Oncology Board Reshuffles Following Director Resignations
Premium
Company Announcements
ALX Oncology Board Reshuffles Following Director Resignations
6M ago
8K
ALXO
ALX Oncology announces initiation of Phase 2 trial in patients with HPVOC
Premium
The Fly
ALX Oncology announces initiation of Phase 2 trial in patients with HPVOC
6M ago
ALXO
Cantor Fitzgerald biotech analyst holds an analyst/industry webinar
PremiumThe Fly
Cantor Fitzgerald biotech analyst holds an analyst/industry webinar
6M ago
ALXO
Cantor Fitzgerald biotech analyst holds an analyst/industry webinar
PremiumThe Fly
Cantor Fitzgerald biotech analyst holds an analyst/industry webinar
6M ago
ALXO
ALX Oncology reports clinical data from Phase 1/2 trial of evorpacept
PremiumThe Fly
ALX Oncology reports clinical data from Phase 1/2 trial of evorpacept
6M ago
ALXO
ALX Oncology price target raised to $20 from $17.50 at H.C. Wainwright
PremiumThe Fly
ALX Oncology price target raised to $20 from $17.50 at H.C. Wainwright
7M ago
ALXO
ALX Oncology price target raised to $21 from $11 at Piper Sandler
PremiumThe FlyALX Oncology price target raised to $21 from $11 at Piper Sandler
7M ago
ALXO
ALX Oncology downgraded to Hold from Buy at Stifel
Premium
The Fly
ALX Oncology downgraded to Hold from Buy at Stifel
7M ago
ALXO
ALX Oncology reports Q4 EPS (93c), consensus (84c)
Premium
The Fly
ALX Oncology reports Q4 EPS (93c), consensus (84c)
7M ago
ALXO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >